Table 3.

Activity of ficolin-3-mediated lectin pathway (F3-LP) in relation to anatomic location of bacterial infections.

Infection type	T2DM n = 197		ND n = 196		Significance
Respiratory	Total: n = 46	67 [23–132]	Total: n = 74	44 [15–89]	NS
	Sepsis: n = 31	52 [12–103]	Sepsis: n = 49	39 [9–74]	NS
UTI	Total: n = 60	67 [20–102]	Total: n = 61	37 [8–79]	p = 0.0456
	Sepsis: n = 40	67 [20–102]	Sepsis: n = 43)	27 [6–73]	p = 0.038
SSTI	Total: n = 75	53 [25–100]	Total: n = 47	68 [18–114]	NS
	Sepsis: n = 31	53 [30–85]	Sepsis: n = 21	72 [10–123]	NS
Other	Total: n = 16	59 [21–136]	Total: n = 14	63 [21–117]	NS

UTI, Urinary tract; SSTI, Skin and soft tissue infections. Due to low case number, sepsis subgroups for “Other” infections are not presented.

“n” indicates number of subjects. Values indicate medians [25–75% percentile] of F3-LP (%). Mann-Whitney test was performed to compare study groups.

The values in bold indicate the medians and the significant differences.